Vector Models and Indexing for Bioequivalence Regulatory

Data Characteristics

Bioequivalence study data primarily originates from pharmaceutical, preclinical, and clinical trial reports, along with relevant regulatory guidelines. Data update frequency is relatively low, typically changing with drug development progress or regulatory revisions. Document structures are mainly structured reports, including study protocols, analytical method validation, subject information, drug concentration data, and statistical analysis results. Core fields include drug concentration (ng/mL), time point (h), subject ID, formulation type (reference/test preparation), and PK parameters (Cmax, AUC0-t, AUC0-inf, Tmax, t1/2, etc.). Units typically follow international standards. The data contains numerous charts and tables, requiring advanced text extraction and structural processing capabilities.

Constraints on Vector Models and Indexing

Bioequivalence reports contain drug concentration-time curves and PK parameter tables. The vector model must extract key information from this complex structured data. Specialized terminology and abbreviations in documents challenge general vector models. Enhance models through domain-specific glossaries or pre-training. Low data update frequency means lower index reconstruction costs, allowing for more refined indexing strategies. The large amount of numerical data and statistical results in reports requires vector models to capture numerical relationships and statistical significance, such as PK parameter ratio intervals. Furthermore, comparing data from different formulation types is central. Index design must support efficient cross-document and cross-field comparative queries.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Segment Length)	`500–800 characters`	Ensures each segment contains complete key information, such as a method description or an explanation of a PK parameter table, without being too long and causing semantic drift.
`Chunk overlap` (Segment Overlap)	`50–100 characters`	Guarantees contextual continuity, preventing critical information from being split across segment boundaries.
`Recall count` (Recall Count)	`8–12 items`	Bioequivalence queries often require comparing multiple data points or report sections. Increase recall count to obtain more comprehensive context.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	High precision is required for terminology and data presentation in this domain. A high threshold helps recall more relevant and accurate results.
`Embedding Model`	`m3e` or `bge-large-zh`	These models perform well with Chinese biomedical texts, understanding specialized terminology and numerical context.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Bioequivalence report files can be large and complex to parse. A longer timeout is needed to prevent parsing interruptions.

Common Mistakes

The knowledge base status displays "Indexing" for an extended period. This can be due to document parsing timeouts or files exceeding system limits. Check logs for PARSE_FILE_TIMEOUT_SECONDS errors or UPLOAD_FILE_MAX_SIZE configuration issues.
Custom index content fails to improve recall accuracy. This happens when indexing is too generalized, not focusing on specific fields or key numerical values within bioequivalence reports, leading to less focused vector representations.
Query results do not effectively compare PK parameters of different formulations. This may occur if the document segmentation strategy does not keep PK parameters and their corresponding formulation types within the same segment, leading to the loss of critical associative information during vectorization.

Verification Steps

Upload a typical bioequivalence report. Observe if the knowledge base indexing completes normally and check the index logs for parsing errors.
Perform retrieval tests for key PK parameters (e.g., Cmax, AUC ratios) and comparisons between different formulations within the report. Check if recalled results include relevant segments.
Query using specialized terminology and abbreviations unique to the report. Verify the accuracy and completeness of the recalled results.
Evaluate if the system can provide effective context, including data for both formulation types, for comparative questions regarding different formulations. For example, query "difference in Cmax between reference and test preparations."

Note: The values provided are common starting points. Measure them against your own samples for optimal performance.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.